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Neglected tropical diseases are major health hazards in developing countries. Annually, up
to 30 million people are affected by either Chagas disease, African trypansomiasis or
leishmaniasis, and more than 200 million by malaria. Most of the currently available drugs
have drawbacks in terms of toxicity, limited oral availability, development of resistance, or
non-affordability. Tropical plants of the arid zones are a treasure chest for the discovery of
bioactive secondary metabolites. This study aims to compile Sudanese medicinal plants,
validate their antiprotozoal activities, and identify active molecules. We have performed a
survey of medicinal plants of Sudan and selected 62 that are being used in Sudanese
traditional medicine. From these, we collected materials such as leaves, stem, bark, or fruit.
The plant materials were extracted in 70% ethanol and further fractionated by liquid-liquid
partitioning using solvents of increasing polarity. This resulted in a library of 235 fractions.
The library was tested in vitro against Plasmodium falciparum (erythrocytic stages),
Trypanosoma brucei rhodesiense (bloodstream forms), Trypanosoma cruzi (intracellular
amastigotes), and Leishmania donovani (axenic amastigotes). Active fractions were also
tested for cytotoxicity. Of the 235 fractions, 125 showed growth inhibitory activity >80% at
10 mg/ml, and >50% at 2 mg/ml against at least one of the protozoan parasites.
Plasmodium falciparum was the most sensitive of the parasites, followed by T. b.
rhodesiense and L. donovani. Only few hits were identified for T. cruzi, and these were
not selective. Contrary to expectation based on phylogeny, but in agreement with previous
results, a large number of extracts displayed mutual activity against T. brucei and P.
falciparum. HPLC-based activity profiling for selected active extracts was performed to
identify the bioactive principles. Active compounds identified by dereplication were
guieranone A from Guiera senegalensis J.F.Gmel.; pseudosemiglabrin from Tephrosia
apollinea (Delile) DC; ellagic acid and quercetin from Terminalia leiocarpa (DC.) Baill.; and
catechin, ethyl gallate, and epicatechin gallate from Vachellia nilotica (L.) P.J.H.Hurter &
Mabb. Also the extracts of Croton gratissimus var. gratissimus and Cuscuta hyalina Roth
ex Schult. exhibited promising antitrypanosomatid activity. This assessment provides a
comprehensive overview of Sudanese medicinal plants and supports the notion that they
are a potential source of bioactive molecules against protozoan parasites.
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Infections by protozoan parasites remain to be among the most
devastating causes of mortality in the tropics. The
trypanosomatids are a large family of flagellated protozoa,
some of which cause neglected tropical diseases of high public
health relevance and socio-economic impact (WHO, n.d.; Filardy
et al., 2018). These are Trypanosoma cruzi (Chagas’ disease), T.
brucei gambiense, and T. b. rhodesiense (human African
trypanosomiasis or sleeping sickness), and Leishmania spp.
(different kinds of leishmaniasis) (Stuart et al., 2008). The
apicomplexan parasite Plasmodium falciparum is the causative
agent of malaria tropica, the most dangerous form of malaria,
which—despite the successes by various international bodies and
philanthropic organizations—still claims an annual death toll of
435,000 (World Health Organisation, 2018). These diseases
disproportionally affect the poor and vulnerable populations
(WHO Expert Committee on Malaria: Twentieth Report, n.d.),
calling for action to improve global well-being. A key element of
the fight against protozoan neglected tropical diseases and
malaria is the discovery of novel chemotherapeutic agents.
While the incidence of human African trypanosomiasis is at a
historic low and a new drug, fexinidazole (Mesu et al., 2018), has
recently received positive opinion by the European Medicines
Agency, the prospects are slightly gloomy for other protozoal
diseases. Chagas’ disease has reached global dimensions (“WHO
| Epidemiology” n.d.), and leishmaniasis as well (“Leishmaniasis”
n.d.). Sudan has the highest incidence of leishmaniasis in sub-
Saharan countries, with 15,000–20,000 new cases per annum
(Hotez and Kamath, 2009). The successful treatment of malaria
is threatened by artemisinin-resistant mutants of P. falciparum,
first reported from Southeast Asia (Ariey et al., 2014; Straimer
et al., 2015; Ménard et al., 2016) and, more recently, also from
Africa (Lu et al., 2017).
Plants are still considered as important sources for the
discovery of novel bioactive molecules. Plants secondary
metabolism represents a huge and unique reservoir of chemical
diversity, which may serve as a source of new drugs, either
directly or after optimization by medicinal chemistry.
Independent chemoinformatic analyses have consistently
shown that natural products often exhibit unique features, a
high degree of structural diversity, and drug- or lead-like
structural properties (Feher and Schmidt, 2003; Schmidt et al.,
2012; Pascolutti et al., 2015).
A retrospective analysis showed that approximately 50% of
drugs approved within the last 30 years are derived, directly or
indirectly, from natural products, whereby plant derived
compounds played an important role (Newman and
Cragg, 2016).
Sudan’s biodiversity coupled with a deeply rooted ethno-
botanical heritage is an untapped reservoir for the discovery of
new bioactive natural products. Here we performed a survey of
plants from Sudan that are used in traditional medicine, with a
focus on malaria and neglected tropical diseases caused by
protozoa. On the basis of this survey a library of plant extracts
was assembled and screened against trypanosomatid parasitesFrontiers in Pharmacology | www.frontiersin.org 2and P. falciparum. Active compounds in the most promising
extracts were tracked with the aid of an activity-driven approach.MATERIALS AND METHODS
Preparation of a Library of Plant Extracts
A total of 62 plants reputed as antiparasitic in traditional
medicine in Sudan were solicited from the repository of
the Faculty of Pharmacy, University of Science & Technology.
The plants belonged to 35 different families, of which the
Combretaceae, Leguminosae, Verbenaceae, Lamiaceae, and
Compositae were the most frequent. Where available, different
parts of a given plant species were included in the study.
The taxonomic identity was confirmed by the Medicinal and
Aromatic Plants Research Institute, Sudan. Voucher specimens
(USTH 01-USTH 62) have been deposited at the Herbarium of
the faculty of Pharmacy, University of Science and Technology,
Omdurman, Sudan.
Dried plant material was milled to coarse powder in a
hammer mill. 100-500 g of powdered material was extracted
for 24 h with 500 ml of 70% ethanol in a magnetic rod stirrer.
Extracts were filtered through Whatman no. 1 filter paper and
concentrated by solvent removal in a rotary vacuum evaporator.
Crude extracts were suspended in water and partitioned
consecutively with petroleum ether, chloroform, ethyl acetate,
and n-butanol. Crude extracts and their respective fractions were
allowed to dry at room temperature, weighed, and reconstituted
in DMSO (10 mg/ml) to serve as stock solutions for antiparasitic
testing. This resulted in a library of 235 samples.
HPLC Analyses and Microfractionation
HPLC analyses were performed on a Shimadzu HPLC system
equipped with photo diode array detector (PDA) (SPD-M20A,
Shimadzu), evaporative light scattering detector (ELSD) (3300,
Alltech), and an electrospray ionization mass spectrometer
(ESIMS) (LCMS-8030, Shimadzu). LabSolutions software was
used for data acquisition and processing. The separation was
performed on a C18 SunFire column (3.0 × 150 mm; 3.5
mm; Waters).
Microfractionation of the active samples was carried out by
analytical RP-HPLC on an LC-MS 8030 system (Shimadzu)
connected with an FC204 fraction collector (Gilson). For each
fraction, a solution of 10 mg/ml was prepared in DMSO. A total
of three injections were performed: 2 × 35 ml with only UV
detection (254 nm) for collection (0.7 mg of fraction in total) and
1 × 35 ml with UV-ELSD-ESIMS detection without collection.
The mobile phase consisted of water with 0.1% formic acid
(A) and acetonitrile with 0.1% formic acid (B). The gradient was
5% to 100% B in 30 min, followed by washing with 100% B for 10
min. The flow rate was 0.4 ml/min. Fractions of 1 min each were
collected from minute 1 to minute 40, resulting in 40
microfractions in total. Microfractions of two successive
injections of a given sample were collected into the
corresponding wells of a 96-deepwell plate. Plates were thenJune 2020 | Volume 11 | Article 865
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2013; Potterat and Hamburger, 2014).
Activity Testing Against Trypanosoma
brucei rhodesiense
In vitro activity was tested against bloodstream-form T. b.
rhodesiense STIB 900, which had been obtained in 1982 from a
Tanzanian patient and adapted to axenic culture (Baltz et al.,
1985). The culture mediumwasMEM supplemented with 25mM
HEPES, 1 g/L additional glucose, 1% MEM nonessential amino
acids, 0.2 mM 2-mercaptoethanol, 1 mM Na-pyruvate, and 15%
heat inactivated horse serum. In the two-concentration assay, 50
µl medium containing the corresponding samples concentration
(10 µg/ml or 2 µg/ml) was added to the wells of a 96 well plate.
For the IC50 determination, a 50-µl medium was added to each
well, and a serial sample dilution of 11 threefold dilution steps
covering a range from 100 to 0.002 mg/ml were prepared. Then
104 T. b. rhodesiense in 50 µl medium was added to the wells, and
the plate was incubated for 72 h at 37 °C in a humidified
atmosphere of 5% CO2. A 10-µl resazurin solution (12.5 mg
resazurin dissolved in 100ml distilled water) was added to each
well and incubated for a further 2 to4 h (Räz et al., 1997). Plate
reading was performed in a Spectramax Gemini XS microplate
fluorometer (Molecular Devices Corporation) using an excitation
wavelength of 536 nm and emission wavelength of 588 nm.
Melarsoprol was used as reference drug. Final in-test DMSO
concentration did not exceed 1%. All assays were performed in
two independent replicates at least.
Activity Testing Against Leishmania
donovani
L. donovani amastigotes strain MHOM/ET/67/L82 were grown
in axenic culture in SM medium at pH 5.4 with 10% heat-
inactivated fetal bovine serum, at 37 °C in a humidified
atmosphere of 5% CO2. In the two-concentration assay, 50 µL
medium containing the corresponding samples concentration
(10 or 2 µg/ml) was added to the wells of a 96 well plate. For the
IC50 determination, 50 µl medium was added to each well and a
serial sample dilution of eleven 3-fold dilution steps covering a
range from 100 to 0.002 mg/ml were prepared. Then 105 L.
donovani amastigotes in 50 µl medium were added to the wells,
and the plate was incubated for 72 h at 37 °C in a humidified
atmosphere of 5% CO2. After 72 h of incubation, 10 ml of
resazurin solution were added to each well and the plates
incubated for another 2 h (Mikus and Steverding, 2000). Plate
reading was performed as described for T. brucei. Miltefosine was
used as reference drug. Final in-test DMSO concentration did
not exceed 1%. All assays were performed in two independent
replicates at least.
Activity Testing Against Trypanosoma cruzi
All tests were performed with the T. cruzi Tulahuen strain
C2C4, which expresses the b-galactosidase (LacZ) gene
(Buckner et al., 1996). L6 rat skeletal myoblasts served as
host cells. Cultures were maintained in RPMI 1640 mediumFrontiers in Pharmacology | www.frontiersin.org 3supplemented with 10% FBS and 1.7 µM L-glutamine at 37°C in
a humidified atmosphere of 5% CO2. Host cells were seeded in
96-well microtitre plates, 2 × 103 per well in 100-µl medium.
After 24 h, 50 µl of a suspension of 1 × 105/ml trypomastigote
T. cruzi were added. The medium was replaced at day 4, test
samples were added, and the plates incubated for further 4 d.
Finally, 50 µl of 2.5× CPRG/Nonidet solution was added to all
wells. A color reaction was visible within 2-6 h, which was
quantified in an absorbance reader at 540 nm (Spectramax).
Benznidazole was used as reference drug. Final in-test DMSO
concentration did not exceed 1%. All assays were performed in
two independent replicates at least.
Activity Testing Against Plasmodium
falciparum
In vitro antimalarial activity was tested against the erythrocytic
stages of P. falciparum NF54, originally isolated from a patient
at Schiphol airport. The parasites were grown in human
erythrocytes in RPMI 1640 supplemented with 0.5%
ALBUMAX® II, 25 mM Hepes, 25 mM NaHCO3 (pH 7.3),
0.36 mM hypoxanthine, and 100 U/ml neomycin and kept in
an atmosphere of 3% O2, 4% CO2, and 93% N2 in humidified
modular chambers at 37°C. In the two-concentration assay,
100 µl medium containing the corresponding samples
concentration (final sample concentration of 10 or 2 µg/ml)
was added to the wells of a 96-well plate. For the IC50
determination, a 50-µl medium was added to each well and a
serial sample dilution of 11 threefold dilution steps covering a
final range from 100 to 0.002 mg/ml were prepared. Then 100-
µl parasite (erythrocytes at 1.25% final hematocrit and 0.3%
final parasitemia) was added. After 48 h of incubation with test
compounds, 0.25 mCi of [3H]hypoxanthine was added per well,
and the plates were incubated for an additional 24 h. Cells were
harvested onto glass-fiber filters, and radioactivity was counted
using a Betaplate liquid scintillation counter. Artemisinin was
used as reference drug. Final in-test DMSO concentration did
not exceed 1%. All assays were performed in two independent
replicates at least.
Clustering According to Antiprotozoal
Activity
Two-way clustering was performed on the bioactivity data
measured at 2 µg/ml (Supplementary Table S1). Percent
inhibition was converted to decimals, and the maximum was
set to 1. For sake of clarity, we included only one fraction per
plant, i.e. the one which had exhibited the highest activity
against any of the four protozoan parasites. Hierarchical
clustering was performed with the Eisen lab programs Cluster
and Treeview (Eisen et al., 1998) using Euclidean distance and
average linkage.
Cytotoxicity Testing
L6 rat skeletal myoblast cells were seeded in 96-well microtiter
plates at 2 × 104 cells/ml in RPMI 1640 medium supplemented
with 10% FBS and 1.7 µM L-glutamine. The cells were allowed toJune 2020 | Volume 11 | Article 865
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incubation, 10 µl of resazurin solution (see above) was added,
and the plates were incubated for an additional 2 h. Plates were
read in a fluorescence scanner at 536 nm excitation and 588 nm
emission wavelength. Podophyllotoxin was used as reference. All
assays were performed in two independent replicates at least.Frontiers in Pharmacology | www.frontiersin.org 4RESULTS
Review of Medicinal Plants From Sudan
Ethnopharmacological literature review based on scholarly
databases (Pubmed, Medline, SciFinder) and other supporting
documents revealed that 34 of the 62 plants had been recordedTABLE 1 | Plants investigated in the present study that have a reported use as anti-infective in traditional medicine.
Plant species Family Vernacular
name
Plant
part
Traditional medicinal use
Abutilon pannosum var. figarianum (Webb) Verdc.
(syn. Abutilon figarianum Webb.)
Malvaceae Humbuk,
Gargadan
Leaves Malaria, hepatoprotective, antibacterial (Mohamed et al., 2010)
Ambrosia artemisiifolia L. (syn. Ambrosia maritima L.) Asteraceae Damsissa Leaves Malaria, kidney stones, renal colic, hypertension (Mahmoud et al.,
1999)
Anethum graveolens L. Apiaceae Shabat, Dill Fruit,
seeds,
oil
Colic, carminative, flatulence, and dyspepsia, joint swelling,
sedative for babies, lactogenic (Jana and Shekhawat, 2010)
Annona muricata L. Annonaceae Leaves Antitumor, antiparasitic (Moghadamtousi et al., 2015)
Argemone mexicana L. Papaveraceae Leaves Malaria, early-stage trypansomiasis (Chibale et al., 2012)
Aristolochia bracteolata Lam. Aristolochiaceae Irg el Agrrab,
Um Galagil
Root Malaria, scorpion stings (Suleiman, 2015)
Azadirachta indica A.Juss. Meliaceae Neem Oil Malaria, antihelminthic (El-Tahir et al., 1999a)
Boswellia papyrifera (Caill. ex Delile) Hochst Burseraceae Luban Gum Cough, respiratory infections (Yagi et al., 2016)
Cardiospermum halicacabum L. Sapindaceae Leaves Malaria, antiparasitic (Waako et al., 2005)
Combretum glutinosum Perr. ex DC. Combretaceae Habeil Seeds Fever, rheumatism (Traore et al., 2014)
Combretum hartmannianum Schweinf. Combretaceae Wood Jaundice, diabetes, rheuma, wound healing, anthelminthic (Khalid
et al., 2012)
Croton gratissimus var. gratissimus (syn. Croton
zambesicus Müll.Arg.)
Euphorbiaceae Um-Geleigla Fruit Malaria, hypertension, menstrual pain (Mohamed and Khan, 2009)
Cymbopogon citratus (DC.) Stapf Poaceae Lemon grass Leaves Kidney stones and infections, malaria (Dike et al., 2012)
Cyperus rotundus L. Cyperaceae Rhizome Fever, stomach disorders, bowel irritation (Kabbashi et al., 2015)
Grewia tenax (Forssk.) Fiori Tiliaceae Godeim Fruits Malaria, iron deficiency (Gebauer et al., 2007)
Guiera senegalensis J.F.Gmel. Combretaceae Gubeish Leaves Jaundice, malaria, hyperglycemia (Suleiman, 2015)
Haplophyllum tuberculatum (Forssk.) A.Juss. Rutaceae Haza Leaves Malaria, asthma, kidney diseases, gynecological, and bowel
disorders (Ahmed et al., 2010; Khalid et al., 2012)
Jatropha curcas L. Euphorbiaceae Habat El
Muluk
Leaves Malaria (O. Abiodun et al., 2011)
Lupinus albus subsp. graecus (Boiss. & Spruner)
Franco & P.Silva (syn. Lupinus termis Forssk.
Leguminosae Tormos Seeds Paste for eczema and herpes zoster (Antoun and Taha, 1981)
Moringa oleifera Lam. Moringaceae Shagarat al
Rawag
Leaves Antimicrobial, antipyretic, antihypertensive, antispasmodic,
antiinflammatory (Ali et al., 2002; Anwar et al., 2007)
Nauclea latifolia Sm. Rubiaceae Karmadoda Fruit,
root
bark
Malaria, abdominal disease, antimicrobial (Benoit-Vical et al., 1998;
Alamin et al., 2015)
Piper cubeba L. f. Piperaceae Fruits Respiratory and intestinal disorders, nephroprotective, anticancer,
antimicrobial (Salehi et al., 2019)
Prosopis chilensis (Molina) Stuntz Leguminosae Miskeet Leaves Antiinflammatory, analgesic (Abodola et al., 2015)
Senna occidentalis (L.) Link (syn. Cassia occidentalis
L.)
Leguminosae Soreib Aerial
part
Malaria, jaundice (Suleiman, 2015)
Striga hermonthica (Delile) Benth. Orobanchaceae Al-buda Stem Malaria (Okpako and Ajaiyeoba, 2004)
Tephrosia apollinea
(Delile) DC
Leguminosae Dhawasi;
Dhafra
Leaves Antiangiogenic, antioxidant antiproliferative, anticancer (Hassan
et al., 2014)
Terminalia laxiflora Engl. Combretaceae Darout Bark Fever and respiratory infections (Salih et al., 2018)
Terminalia leiocarpa (DC.) Baill. (syn. Anogeissus
leiocarpa (DC.) Guill. & Perr.)
Combretaceae Sahab Bark Cough, dysentry, giardiasis (Musa et al., n.d.)
Typha angustifolia L. Typhaceae Si’da Stem Leprosy wound bleeding, diarrhoea, anthelminthic, diuretic (Varpe
et al., 2012)
Vachellia nilotica (L.) P.J.H.Hurter & Mabb. (syn.
Acacia nilotica (L.) Delile)
Fabaceae Sunt Leaves Malaria (El-Tahir et al., 1999b), respiratory infections, diarrhoea,
haemorrhage (Clarkson et al., 2004)
Xanthium strumarium subsp. brasilicum (Vell.)
O.Bolòs & Vigo (syn. Xanthium brasilicum Vell.)
Compositae Leaves Malaria (Chandel et al., 2012)
Tinospora bakis (A.Rich.) Miers Menispermaceae Irg alhagar Root Fever, diarrhoea, abdominal pain (Ahmed et al., 2010)
Ziziphus spina-christi (L.) Desf. Rhamnaceae Sidir Leaves Fever, spasmolytic, and anti- diarrhea (Khalid et al., 2012)June 2020 | Volume 11 | Article 865
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including the symptoms related to any of these diseases
(Table 1). Several of the plants had also been investigated
pharmacologically and had exhibited anti-infective activity
(Table 2).Frontiers in Pharmacology | www.frontiersin.org 5Testing for Antiparasitic Activity
The original extracts and all fractions obtained by partitioning
were tested at two concentrations, 2 and 10 mg/ml, against the
following panel of protozoan parasites: T. b. rhodesiense
bloodstream form, T. cruzi intracellular amastigote form grownTABLE 2 | Plants investigated in the present study for which anti-infective properties have been examined experimentally.
Plant species Part Tested activities IC 50 value Active metabolite(s) Ref
Anethum graveolens L. Leaves Antiplasmodial – Volatile oils (Chibale et al., 2012)
Annona muricata L. Leaves Antileishmanial 25 µg/ml Acetogenins (Osorio et al., 2007)
Argemone mexicana L. Leaves Antiplasmodial 1.7 mg/ml Protopine, allocryptopine, and
berberine
(Simoes-Pires et al., 2014)
Aristolochia bracteolata Lam. Root Antiplasmodial < 5 mg/ml – (El-Tahir et al., 1999b)
Azadirachta indica A.Juss. Leaves Antiplasmodial 2.5 mg/ml Gedunin (Khalid et al., 1989a; MacKinnon
et al., 1997)
Cardiospermum halicacabum L. Leaves Antiplasmodial 42 µg/ml – (Kaushik et al., 2015)
Combretum glutinosum Perr. ex DC. Leaves Trypanocidal 26.5 µg/ml – (Traore et al., 2014)
Combretum hartmannianum Schweinf. Bark Antiplasmodial 0.2 mg/ml – (Ali et al., 2002)
Commiphora myrrha (Nees) Engl. Gum
resin
Trypanocidal 8.1 mg/ml – (Okba et al., 2018)
Croton gratissimus var. gratissimus (syn.
Croton zambesicus Müll.Arg.)
Root Antiplasmodial – Sesquiterpenes,
monoterpenes, and alkaloids
(Okokon and Nwafor, 2009)
Curcuma longa L. Rhizome Antiplasmodial 3- 4.2 mg/ml Curcumin,
demethoxycurcumin, and bis-
demethoxycurcumin.
(Rasmussen et al., 2000)
Cymbopogon citratus (DC.) Stapf Leaves Antiplasmodial – Essential oils (Tchoumbougnang et al., 2005)
Cyperus rotundus L. Whole
plant
Antiplasmodial – Terpenes, monoterpenes, and
sesquiterpenes.
(Peerzada et al., 2015)
Guiera senegalensis J.F.Gmel. Leaves
and
roots
Antiplasmodial 4.08 µM Guiranone A (Silva and Gomes, 2003)
Haplophyllum tuberculatum (Forssk.)
A.Juss.
Leaves (1) Antileishmanial
(2) Trypanocidal
(1) 16.59 mg/ml and
(2)
0.2 mg/ml
(1) R-(+)-limonene
(2) Justicidin B
(Gertsch et al., 2003; Hemmati
and Seradj, 2016; Hamdi et al.,
2018)
Jatropha curcas L. Seeds Trypanocidal 1.9 µg/ml (T.
brucei) and 7.4 µg/
ml, (T. cruzi)
Phorbol esters (Khalid, 2012)
Mangifera indica L. Stem
bark
Antiplasmodial >50 µg/ml – (Zirihi et al., 2005)
Moringa oleifera Lam. Leaves Antileishmanial 5.25 µM Niazinin (Kaur et al., 2014)
Nauclea latifolia Sm. Stem
and root
Antiplasmodial 0.9-3 µg/ml Alkaloids
tetrahydrodesoxycordifoline
and 19-O-methylangustoline
(Benoit-Vical et al., 1998;
Boucherle et al., 2016)
Piper cubeba L. f. Fruits Antitrypanosomal
against T. cruzi
amastigotes
87.9 µg/ml Essential oil (Esperandim et al., 2013)
Senna occidentalis (L.) Link (syn. Cassia
occidentalis L.)
Leaves Antiplasmodial <3 µg/ml Anthraquinones, terpenes, and
flavonoids.
(Tona et al., 2004)
Striga hermonthica (Delile) Benth. Whole
plant
Antiplasmodial 274.8 µg/ml – (Okpako and Ajaiyeoba, 2004)
Terminalia leiocarpa (DC.) Baill. (syn.
Anogeissus leiocarpa (DC.) Guill. & Perr.)
Bark Antiplasmodial 19 µg/ml Ellagic acid, gallic acid, and
gentisic acid
(Ndjonka et al., 2012)
Tinospora bakis (A.Rich.) Miers Roots Antiplasmodial 28.6 µg/ml Alkaloids (Ouattara et al., 2006)
Vachellia nilotica (L.) P.J.H.Hurter & Mabb.
(syn. Acacia nilotica (L.) Delile)
Seed Antiplasmodial 1.5 µg/ml Terpenoids and tannins. (El-Tahir et al., 1999b)
Xanthium strumarium subsp. brasilicum
(Vell.) O.Bolòs & Vigo (syn. Xanthium
brasilicum Vell.)
Aerial
parts
Antiplasmodial,
Antitrypanosomal
0.09 µg/ml (T.
brucei), 2.95 µg/ml
(T. cruzi), 0.16 µg/
ml (L. donovani),
and 1.71 µg/ml
(P.falciparum)
8-Epixanthatin 1beta,5beta-
epoxide
(Nour et al., 2009)
Ziziphus spina-christi (L.) Desf. Leaves Antileishmanial >30 µg/ml – (Ali et al., 2002)June 2020 | Volume 11 | Article 865
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pH, and P. falciparum erythrocytic stage grown in human
erythrocytes. Percent inhibition was calculated in comparison
to untreated controls. All tests were carried out in independent
duplicates. The results are compiled in Supplementary Table S1.
Extracts that exhibited >80% growth inhibition at 10 mg/ml,
or >50% growth inhibition at 2 mg/ml against at least one of the
tested parasites was considered active. Of the 235 extracts in our
library, 125 (53%) fulfilled these activity criteria. A total of 34
(27%) of the active extracts exhibited activity against T. b.
rhodesiense, L. donovani, and P. falciparum collectively.
Regarding parasite species-selective inhibition, P. falciparum
appeared to be the most susceptible parasite, followed by T. b.
rhodesiense and L. donovani. Among the tested parasites T. cruzi
was the least susceptible towards the plant extracts (Figure 1).
Two-Way Clustering of the Bioactivity
Data
We used the screening results obtained with 2 µg/ml for two-way
clustering, i.e. clustering the plants according to their bioactivity,
and clustering the parasites according to their susceptibility
(Figure 2). Per plant only one fraction from the partitioning
was included, i.e. the one which had displayed the highest activity
against any of the four parasites. This approach clearly confirmed
the notion that T. b. rhodesiense and P. falciparum, despite their
large phylogenetic distance, have a similar susceptibility profile.
It also highlighted T. cruzi as the least susceptible of the four
tested parasites (Figure 2). There was no clear separation
between the medicinal plants with reported anti-infective use
(printed in red in Figure 2) and the rest. Regarding
antiplasmodial activity, the plants that had a reported use
against malaria (n=17; Table 1) were slightly more activeFrontiers in Pharmacology | www.frontiersin.org 6against P. falciparum in vitro, both at 2 µg/ml (mean inhibition
of 43% vs. 39%) and at 10 µg/ml (mean inhibition of 89% vs.
75%). However, these differences were not statistically significant
(p=0.70, two-tailed Mann-Whitney test).
Testing for Cytotoxicity
Extracts with antiparasitic activity were also tested for
cytotoxicity. This was done against rat L6 skeletal myoblast
cells, the same cell line that had been used as host cells forFIGURE 1 | Susceptibility of parasites against a library of Sudanese
medicinal plants. Activity criteria: >80% growth inhibition at 10 mg/ml or >50%
growth inhibition at 2 mg/ml against one or more of the four included
parasites. Venn diagram drawn with (https://bioinfogp.cnb.csic.es/tools/
venny/).FIGURE 2 | Heat map showing two-way clustering of bioactivity of extracts,
and of parasites.June 2020 | Volume 11 | Article 865
Mahmoud et al. Mining Sudanese Medicinal Plantstesting against amastigote T. cruzi. Concentration-response
curves allowed the calculation of both 50% and 90% inhibitory
concentrations (IC50 and IC90; Table 3). The cytotoxicity data of
the tested fractions cannot directly be compared to their
antiparasitic activity because the antiparasitic and cytotoxic
activity of a given fraction can be due to different molecules.
Nevertheless, the aim was to identify non-toxic fractions for the
following HPLC-based activity profiling and identification of
active compounds.
Extracts With Selective Anti-
Trypanosomatid Activity
The most potent and selective activity against T. b. rhodesiensewas
exhibited by the chloroform fraction of the leaves of Terminalia
catappa L. (Combretaceae), which showed 98% inhibition at 10
µg/ml and 80% inhibition at 2 µg/ml. Five of the ethyl acetate
fractions showed growth inhibition > 85% at 10 µg/ml: fruits of
Croton gratissimus var. gratissimus (syn. Croton zambesicusMuell.
Arg. (Euphorbiaceae), processed fruits of Nauclea latifolia Sm.
(Rubiaceae), leaves of Lippia lacunosa Mart. & Schauer
(Verbenaceae), and Xanthium strumarium subsp. brasilicum
(Vell.) O.Bolòs & Vigo (syn. Xanthium brasilicum Vell.)
(Compositae), and the mango Mangifera indica L. fruit peels
(Anacardiaceae). In addition, the water fraction of processed
fruits of Nauclea latifolia. showed significant inhibition of T. b.
rhodesiense at the two tested concentrations.
Only five percent of the library extracts were preferentially
active against L. donovani. These were mostly lipophilic, e.g., the
chloroform fraction of Ambrosia artemisiifolia L. (syn. Ambrosia
maritima L.) (Asteraceae) leaves and the petroleum ether
fractions of Piper cubeba L. f. (Piperaceae) fruits, Portulaca
oleracea L. (Portulacaceae) aerial parts, and Typha angustifolia
L. (Typhaceae) stem.
Trypanosoma cruzi was the least sensitive among the tested
parasites. Only the crude extract of Annona muricata L.
(Annonaceae) leaves and the methanolic fraction of
Commiphora myrrha (Nees) Engl. (Burseraceae) oil and resinFrontiers in Pharmacology | www.frontiersin.org 7inhibited the growth of intracellular T. cruzi more than 50% at 2
µg/ml. However, these activities were not specific for T. cruzi
(Figure 1, Supplementary Table S1).
Extracts of Selective Antiplasmodial Activity
Thirteen fractions showed >80% growth inhibition of P. falciparum
at 10 µg/ml, but none showed >50% growth inhibition at 2 µg/ml.
Among the most active ones were the chloroform fraction of
Cuscuta hyalina Roth ex Schult.(Convolvulaceae) stem and the
ethyl acetate fractions of the leaves of Abutilon pannosum var.
figarianum (Webb) Verdc. (syn. Abutilon figarianum Webb)
(Malvaceae), Annona muricata, Tephrosia apollinea (Delile) DC
(Leguminosae), and Cardiospermum halicacabum L. Moreover,
both the chloroform and the ethyl acetate fractions of the leaves
of Cymbopogon citratus (DC.) Stapf (Poaceae) exhibited selective
antiplasmodial activity above 80% inhibition at 10 µg/ml. However,
the ethyl acetate fraction, in particular, exhibited cytotoxicity on L6
cells with an IC50 of 53.8 µg/ml (Table 3).
HPLC-Based Activity Profiling
The ethyl acetate fraction of Ziziphus spina-christi (L.) Desf.
(Rhamnaceae) leaves had shown >80% growth inhibition at 10
µg/ml, and >50% inhibition at 2 µg/ml across all parasites
(Supplementary Table S1). HPLC-based activity profiling
revealed that the time-windows of antiparasitic activity against
L. donovani on the one side, and against T. b. rhodesiense and P.
fa lc iparum on the other s ide , were different . The
antitrypanosomal and antiplasmodial activity was associated
with more polar, earlier eluting compounds, while the
antileishmanial activity was located in the more lipophilic and
later eluting compounds (Figure 3).
In the chloroform fraction of Guiera senegalensis J.F.Gmel.
(Combretaceae) leaves the two time windows of activity against
T. b. rhodesiense and P. falciparum were identical (Figure 4),
likely indicating molecules of dual activity. However, the
chloroform fraction also had a relatively high cytotoxicity
(IC50 = 16 µg/ml; Table 3).TABLE 3 | Cytotoxicity of antiprotozoal extracts as determined against rat L6 skeletal myoblast cells in vitro.
Plant Part Fraction Cytotoxicity [µg/ml]
IC50 IC90
Ambrosia artemisiifolia L. (syn. Ambrosia maritima (L.)) Leaves Ethyl acetate 38.1 85.8
Annona muricata L. Leaves Chloroform 20.3 71.3
Argemone mexicana L. Leaves Ethyl acetate 58.5 91.9
Boswellia papyrifera (Caill. ex Delile) Hochst Gum Petroleum ether 31.6 83.5
Commiphora myrrha (T.Nees) Engl. Gum Methanol 5.5 9.9
Croton gratissimus var. gratissimus (syn. Croton zambesicus Müll.Arg.) Fruits Chloroform 32.5 81.8
Cuscuta hyalina Roth ex Schult. Stem Chloroform 19.6 30.2
Cymbopogon citratus (DC.) Stapf Leaves Ethyl acetate 53.8 N/Aa
Cyperus rotundus L. Rhizome Ethyl acetate 64.3 N/Aa
Guiera senegalensis J.F.Gmel. Leaves Ethyl acetate 16.0 67.8
Haplophyllum tuberculatum (Forssk.) A.Juss. Root Chloroform 6.3 10.3
Moringa oleifera Lam. Leaves Ethyl acetate 89.6 N/Aa
Prosopis chilensis (Molina) Stuntz Leaves Chloroform 5.9 9.8
Struthanthus concinnus Mart. Branches Ethyl acetate 44.6 86.1
Tephrosia apollinea (Delile) DC Leaves Chloroform 15.5 51.8
Vachellia nilotica (L.) P.J.H.Hurter & Mabb. (syn. Acacia nilotica (L.) Delile Leaves Ethyl acetate 21.5 83.0
Xanthium strumarium subsp. brasilicum (Vell.) O.Bolòs & Vigo (syn. Xanthium brasilicum Vell.) Leaves Petroleum ether 13.3 28.8June 2020 | Volume 11 |aN/A, not achievable.Article 865
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B
FIGURE 4 | HPLC-ESIMS (base peak chromatogram) and activity profile of a chloroform fraction from leaves of Guiera senegalensis J.F.Gmel. Similar time window
for trypanocidal (A) and antiplasmodial activity (B) was found. Peak 1 refers to guieranone A.A
B
FIGURE 3 | HPLC-based activity profiling of an ethyl acetate fraction from leaves of Ziziphus spina-christi (L.) Desf. The ELSD chromatogram of the fraction
separation on an analytical RP-HPLC column is shown. Activity of the 1-min micro-fractions is indicated for trypanocidal (A) and antileishmanial activity (B),
expressed as % of growth inhibition.Frontiers in Pharmacology | www.frontiersin.org June 2020 | Volume 11 | Article 8658
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HPLC-based activity profiling, in combination with on-line
spectroscopic data (MS and UV) and comparison with natural
products databases was used to dereplicate known active
compounds. The antiplasmodial activity of Guiera senegalensis
J.F.Gmel was in accordance with previous reports. In the window
of activity a HPLC peak was detected which exhibited a [M+H]+
ion at m/z 316 in the MS, and lmax 241 and 276 nm in the UV
spectrum. This peak was assigned to guieranone A (MW 316.35
g/mol), a compound previously reported from this species (Silva
and Gomes, 2003). The chloroform fraction of Tephrosia
apollinea (Delile) DC. leaves was active against three parasites
(Supplementary Table S1), as well as cytotoxic in L6 cells
(Table 3). In the window of activity a HPLC peak exhibiting a
[M+H]+ ion at m/z 393 in the ESIMS, and lmax 256 and 310 nm
in the UV spectrum corresponded to pseudosemiglabrin, a major
secondary metabolite in this plant (Waterman and Khalid, 1980),
of known antioxidant and anti-inflammatory activity.
The ethyl acetate fraction of the leaves, roots, and seeds of
Terminalia leiocarpa (DC.) Baill. (syn. Anogeissus leiocarpa (DC.)
Guill. & Perr.) (Combretaceae) exhibited promising inhibitory
activity against T. b. rhodesiense and P. falciparum (Figure 5). In
the active time window HPLC peaks with MS and UV data
indicative for ellagic acid and quercetin were seen, and their
identity was confirmed by co-injection of authentic samples. The
two compounds have been previously reported from T. leiocarpa
(Ndjonka et al., 2012; Oboh et al., 2017). Ellagic acid has been
previously shown to possess antiplasmodial activity (Banzouzi et al.,
2002) which has been attributed to the inhibition of beta-haematin
formation in the parasite (Dell’Agli et al., 2003). The antiplasmodial
activity of quercetin (Ganesh et al., 2012) has been associated with
the inhibition of a parasite protein kinase (Wiser et al., 1983). The
leaf extract of Vachellia nilotica (L.) P.J.H.Hurter & Mabb. (syn.
Acacia nilotica (L.) Delile) (Fabaceae) inhibited T. b. rhodesiense and
P. falciparum at 2 µg/ml, andmoderate cytotoxicity (IC50 of 21.5 µg/
ml against L6; Table 3). In the HPLC activity profile (Figure 6)
peaks with [M+H]+ ions at m/z 291.0 and m/z 442.9 in the ESIMS,
and with lmax 277 and 280 nm in the UV spectra were detected inFrontiers in Pharmacology | www.frontiersin.org 9the active time window. These peaks corresponded to catechin
(Wulf et al., 2008) and epicatechin gallate (Salem et al., 2011),
respectively. The occurrence of these compounds in V. nilotica has
been reported (Khalid et al., 1989b; Dikti Vildina et al., 2017).
Catechins were found to possess antiplasmodial activity by
inhibiting both the ATPase and chaperone functions of the P.
falciparum heat shock proteins (PfHsps) through direct binding to
PfHsp70-1 and PfHsp70-z (Zininga et al., 2017). In addition, a peak
corresponding to ethyl gallate was detected in the active time
window. Gallate esters are known inhibitors of trypanosome
alternative oxidase, and they can increase intracellular glycerol to
toxic levels resulting in trypanocidal activity (Jeacock et al., 2017).
However, we cannot exclude that ethyl gallate was formed from
gallic acid during ethanol extraction.DISCUSSION
A total of 62 Sudanese plants were selected on the basis of their
traditional use as medicinal plants, with an emphasis on plants that
had been used to treat protozoal diseases. Of these plants a library of
235 extracts was prepared and tested against four protozoan
parasites: Plasmodium falciparum (erythrocytic stages),
Trypanosoma brucei rhodesiense (bloodstream forms),
Trypanosoma cruzi (intracellular amastigotes), and Leishmania
donovani (axenic amastigotes). The methods used were standard
in vitro tests for drug discovery, where the measured signals
correlated with the number of parasites. Screening of the library
resulted in 125 potential hits that fulfilled the chosen activity criteria,
i.e. > 80% growth inhibition at 10 mg/ml or >50% growth inhibition
at 2 mg/ml against one or more of the four parasites. A total of 11
extracts were solely active against T. b. rhodesiense, 13 against P.
falciparum, and 5 against L. donovani. A total of 27 extracts
exhibited activity against three parasites. The percentage of
extracts that displayed activity against both T. brucei and P.
falciparum (21%) was considerably higher than that with activity
against T. brucei and L. donovani (5%), despite the fact that
trypanosomes and leishmania are taxonomically relatedFIGURE 5 | HPLC-PDA antiplasmodial activity profiling of the ethyl acetate fraction of the leaves of Terminalia leiocarpa (DC.) Baill. recorded at 254 nm. Peaks 3 and
4 refer to ellagic acid and quercetin, respectively.June 2020 | Volume 11 | Article 865
Mahmoud et al. Mining Sudanese Medicinal Plantstrypanosomatid parasites. This somehow surprising result is in
agreement with previous screening campaigns reports (Mokoka
et al., 2011; Kaiser et al., 2015; Llurba Montesino et al., 2015). The
lack of overlap between activity against T. cruzi and L. donovani is
not unusual and has been documented previously (Witschel et al.,
2012; Zulfiqar et al., 2017). They are different parasites living in
different compartments, i.e. cytoplasma for T. cruzi but acidic
environment for Leishmania.
Interestingly, a major part of these extracts were from
plants of the family Combretaceae (Guiera senegalensis
J.F.Gmel., T. leiocarpa (DC.) Baill., Combretum glutinosum
Perr. ex DC., Combretum indicum (L.) DeFilipps (syn.
Quisqualis indica L.), and Terminalia laxiflora Engl.). Plants
of this family are known to be rich in phenolic compounds.
The lowest number of hits was found for T. cruzi. This may be
due, in part, to the fact that T. cruzi amastigotes (which are the
clinically relevant stages for chemotherapy) cannot be grownFrontiers in Pharmacology | www.frontiersin.org 10axenically. Hence, activity can only be identified if the
antiparasitic activity against T. cruzi is significantly higher
than cytotoxicity in L6 cells used for culturing the parasite.
Our findings corroborate previously reported activities of some
plants, e.g. for Z. spina-christi (Mubaraki et al., 2017), G.
senegalensis (Fiot et al., 2006), Terminalia spp. and X.
strumarium (Nour et al., 2009; Abiodun et al., 2012; Ndjonka
et al., 2012). Antiprotozoal activities of some other plants are
reported here for the first time, e.g. the antitrypanosomal activity
of Cuscuta hyalina Roth ex Schult., Combretum indicum (L.)
DeFilipps, and Croton gratissimus var. gratissimus. HPLC activity
profiling, in combination with on-line spectroscopy, enabled a rapid
identification of some of the active compounds by dereplication
(Figure 7), i.e. guieranone A (1) from G. senegalensis,
pseudosemiglabrin (2) from T. apollinea, ellagic acid (3), and
quercetin (4) from T. leiocarpa, and catechin (5), ethyl gallate (6),
and epicatechin gallate (7) from V. nilotica. HPLC-based activityA
B
C
FIGURE 6 | HPLC-UV trace of the ethyl acetate fraction of Vachellia nilotica (L.) P.J.H.Hurter & Mabb. leaves detected at 254 nm, and the % of inhibition of the 1-
min micro-fractions against Trypanosoma brucei rhodesiense (A), Leishmania donovani (B), and Plasmodium falciparum (C). Peaks 5 to 7 refer to catechin, ethyl
gallate, and epicatechin gallate, respectively.June 2020 | Volume 11 | Article 865
Mahmoud et al. Mining Sudanese Medicinal Plantsprofiling will also be of use for the identification of antiprotozoal
compounds from promising Sudanese plants such as Croton
gratissimus var. gratissimus and Cuscuta hyalina Roth ex Schult.,
which exhibited interesting antitrypanosomatid activity. In
summary, we have compiled a comprehensive library of Sudanese
medicinal plants and demonstrate that they are a promising source
of bioactive molecules against protozoan parasites.DATA AVAILABILITY STATEMENT
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